Kaiser Permanente on Friday announced the next deal to build out its Risant Health network of health systems.
Risant plans to acquire North Carolina’s Cone Health, a Greensboro, N.C.-based system with four acute-care hospitals, more than 700 doctors, and — crucially for Risant — an accountable care organization and a health plan.
Terms of the deal weren’t disclosed, and neither Kaiser nor Cone immediately responded to requests for comment.
Primary Mediastinal B-Cell Lymphoma disease is an indication for drug development with over 140 pipeline drugs currently active according to GlobalData.
Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality rates.
Evolva Holding SA / Key word(s): Regulatory Approval Evolva receives approval for Veri-teTM Resveratrol in Thailand 06.09.2023 / 07:00 CET/CEST PRESS RELEASE Evolva receives approval
